These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 283081

  • 21. [Treatment of patients with hemophilia A having antibodies to factor VIII].
    Lopaciuk S, Ziemski JM.
    Acta Haematol Pol; 1979; 10(2):115-22. PubMed ID: 474044
    [Abstract] [Full Text] [Related]

  • 22. [Prevalence of inhibitors in hemophiliacs with reference to the transfusion of blood products (author's transl)].
    Kamiya T.
    Rinsho Byori; 1978; 26(4):291-7. PubMed ID: 671775
    [No Abstract] [Full Text] [Related]

  • 23. [Teeth extractions in 35 patients with hemophilia].
    Zhou SM, Gi LX, Yang TY.
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1994 Sep; 29(5):291-3. PubMed ID: 7743865
    [No Abstract] [Full Text] [Related]

  • 24. Treatment of hemophilia complicated by inhibitors.
    Scand J Haematol Suppl; 1980 Sep; 35():135-64. PubMed ID: 6770458
    [No Abstract] [Full Text] [Related]

  • 25. Management of a lacerated frenum and lip in a child with severe hemophilia and an inhibitor: report of case.
    Powell D.
    ASDC J Dent Child; 1976 Sep; 43(4):272-5. PubMed ID: 783228
    [No Abstract] [Full Text] [Related]

  • 26. [Transfusion therapy of hemophilia A and B].
    Egli H.
    Bibl Haematol; 1967 Sep; 27():204-10. PubMed ID: 5595089
    [No Abstract] [Full Text] [Related]

  • 27. Is a change of factor VIII product a risk factor for the development of a factor VIII inhibitor?
    Yee TT, Lee CA.
    Thromb Haemost; 1999 May; 81(5):852. PubMed ID: 10365768
    [No Abstract] [Full Text] [Related]

  • 28. [Poly-electrolyte fractionated porcine factor VIII in the treatment of hemophilia A].
    Ferencz T, Skopál J, Csáki C, Laczkó M, Schuler D, Borsi J.
    Orv Hetil; 1993 Dec 26; 134(52):2873-5. PubMed ID: 8272354
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Inhibitors in young boys with haemophilia.
    Lusher JM.
    Baillieres Best Pract Res Clin Haematol; 2000 Sep 26; 13(3):457-68. PubMed ID: 11030045
    [Abstract] [Full Text] [Related]

  • 31. Hemostasis in acquired hemophilia--role of intracavitary instillation of EACA.
    Sahu S, Raipancholia R, Pardiwalla FK, Pathare AV.
    J Postgrad Med; 1996 Sep 26; 42(3):88-90. PubMed ID: 9715327
    [Abstract] [Full Text] [Related]

  • 32. Immunological aspects of inhibitor development.
    Reding MT.
    Haemophilia; 2006 Dec 26; 12 Suppl 6():30-5; discussion 35-6. PubMed ID: 17123391
    [Abstract] [Full Text] [Related]

  • 33. Products for the treatment of hemophilia A and B prepared by ion exchange chromatography.
    Sultan Y, Boyeldieu D, Stieltjes N.
    Nouv Rev Fr Hematol (1978); 1994 Dec 26; 36 Suppl 1():S59-60. PubMed ID: 8177717
    [Abstract] [Full Text] [Related]

  • 34. Correlation of antibodies to LAV/HTLV III in hemophiliacs with the use of virus-inactivated clotting factors.
    Dietz B, Klose HJ, Gürtler L, Eberle J, Deinhardt F, Köhler-Vajta K, Peller P.
    Thromb Haemost; 1986 Aug 20; 56(1):50-2. PubMed ID: 3095947
    [Abstract] [Full Text] [Related]

  • 35. Acquired haemophilia A: errors in the diagnosis.
    Kazmi MA, Pickering W, Smith MP, Holland LJ, Savidge GF.
    Blood Coagul Fibrinolysis; 1998 Oct 20; 9(7):623-8. PubMed ID: 9863711
    [Abstract] [Full Text] [Related]

  • 36. Prevalence of factor VIII inhibitors in patients with hemophilia A in Brazil.
    Rieger A, Roisenberg I.
    Thromb Haemost; 1999 Mar 20; 81(3):475-6. PubMed ID: 10102489
    [No Abstract] [Full Text] [Related]

  • 37. [Clinical evaluation of factors VIII and IX manufactured in Hungary, based on results of the first half year].
    Nemes L, Ceglédi A, Szabó G, Varga M, Sas G.
    Orv Hetil; 1998 Mar 29; 139(13):749-52. PubMed ID: 9578703
    [Abstract] [Full Text] [Related]

  • 38. Factors affecting choice of hemostatic agent for the hemophilia patient with an inhibitor antibody.
    Monahan PE, Aledort LM, Hemophilia Inhibitor Study Group.
    Am J Hematol; 2004 Dec 29; 77(4):346-50. PubMed ID: 15558804
    [Abstract] [Full Text] [Related]

  • 39. Treatment of haemophilia.
    Ludlam CA.
    Br J Haematol; 1998 May 29; 101 Suppl 1():13-4. PubMed ID: 9607736
    [No Abstract] [Full Text] [Related]

  • 40. Safety and efficacy of purified factor IX concentrate and antifibrinolytic agents for dental extractions in hemophilia B.
    Djulbegovic B, Marasa M, Pesto A, Kushner GM, Hadley T, Joseph G, Goldsmith G.
    Am J Hematol; 1996 Feb 29; 51(2):168-70. PubMed ID: 8579061
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.